Target intelligence / Profile preview

Antioxidative activity

Molecular classification
Other
01

Overview

Antioxidative activity is a physiological and chemical property characterized by the ability to neutralize reactive oxygen species (ROS) and inhibit oxidative damage to lipids, proteins, and DNA (Reddy et al., 2017). It is not a specific molecular target like a protein or receptor, but rather a functional outcome of various endogenous systems—such as the enzymes superoxide dismutase (SOD) and catalase—and exogenous antioxidants like vitamins C and E (NIH, 2018). In clinical contexts, enhancing antioxidative activity is a key strategy for treating oxidative stress-related conditions, including neurodegenerative diseases like amyotrophic lateral sclerosis (ALS) and cardiovascular disorders (Nagase et al., 2021). Drugs may exert this activity through direct radical scavenging (e.g., edaravone) or by activating the Nrf2-ARE signaling pathway to boost the body's natural defenses (Mika & Kostrzewa, 2021). Because it represents a broad biological effect rather than a single druggable entity, antioxidative activity is classified as a therapeutic property or mechanism of action rather than a specific molecular target (Cvetnić et al., 2022).

Other names
Antioxidant capacityFree radical scavenging activityRedox bufferingAntioxidant potential
02

Mechanism of action

Compounds typically exert antioxidative activity through direct chemical neutralization (scavenging) of free radicals, chelation of pro-oxidant transition metals (e.g., iron, copper), or by activating endogenous defense pathways such as the Nrf2-Keap1-ARE signaling axis to upregulate protective enzymes like superoxide dismutase and catalase.

03

Biological functions

Redox homeostasisOxidative stress responseFree radical neutralizationCellular protectionSignal transduction
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseInflammationDiabetes mellitusAging-related disorders
05

Safety considerations

Antioxidant paradox (potential pro-oxidant effects at high concentrations)Interference with essential ROS-mediated cell signaling (hormesis)Potential reduction in efficacy of ROS-dependent therapies such as radiation or certain chemotherapiesBlunting of beneficial physiological adaptations to exercise
06

Interacting drugs

Edaravone

6 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)8-hydroxy-2'-deoxyguanosine (8-OHdG)Glutathione/Glutathione disulfide (GSH/GSSG) ratioTotal Antioxidant Capacity (TAC)F2-isoprostanes

Beyond the preview

Go deeper on Antioxidative activity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antioxidative activity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call